Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 880 to 929 of 3730 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
440\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
limbic system-associated membrane protein precursor (lsamp). [source:swissprot;acc:q13449]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6830.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7000.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02491\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
441\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6158\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6303\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02355\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
grancalcin. [source:swissprot;acc:p28676]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6251.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7192.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15038\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
442\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
repressor of estrogen receptor activity; b-cell associated protein. [source:refseq;acc:nm\_007273]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6699.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6856.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02335\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6251.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7192.17\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.15038\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
443\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brg1-binding protein eld/osa1; eld (eyelid)/osa protein. [source:refseq;acc:nm\_020732]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6252.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7192.51\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s27-like protein; 40s ribosomal protein s27 isoform. [source:refseq;acc:nm\_015920]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2432.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2379.52\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02223\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
444\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s27 (metallopan-stimulin 1) (mps-1). [source:swissprot;acc:p42677]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
2431.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2378.99\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable rrna processing protein ebp2 (ebna1 binding protein 2) (nucleolar protein p40). [source:swissprot;acc:q99848]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3758.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4322.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15011\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
445\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ad24 protein. [source:refseq;acc:nm\_022451]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3753.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4315.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14978\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mstp028 protein. [source:refseq;acc:nm\_031954]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
9988.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9808.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01835\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
446\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mevalonate kinase (ec 2.7.1.36) (mk). [source:swissprot;acc:q03426]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1549.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1522.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01787\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleostemin; putative nucleotide binding protein, estradiol-induced. [source:refseq;acc:nm\_014366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3766.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4329.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14958\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
447\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s3a. [source:swissprot;acc:p49241]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2929.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2879.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01735\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pescadillo homolog 1. [source:swissprot;acc:o00541]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3751.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4310.89\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14922\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
448\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ponsin; sh3-domain protein 5 (ponsin). [source:refseq;acc:nm\_015385]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6259.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7190.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14884\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein disulfide isomerase precursor (pdi) (ec 5.3.4.1) (prolyl 4- hydroxylase beta subunit) (cellular thyroid hormone binding protein) (p55). [source:swissprot;acc:p07237]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
524.415\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
533.236\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01682\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
449\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
segment polarity protein dishevelled homolog dvl-1 (dishevelled-1) (dsh homolog 1). [source:swissprot;acc:o14640]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5699.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5607.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01634\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein 12 (ytm1 homolog). [source:swissprot;acc:q9gzl7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3761.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4319.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14837\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
450\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj153g14.2 (possible ca binding protein similar to nefa) (fragment). [source:sptrembl;acc:q9ujn8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4158.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4094.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01569\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
l-myc-1 proto-oncogene protein. [source:swissprot;acc:p12524]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4889.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14753\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
451\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 10 (26s proteasome regulatory subunit p28) (gankyrin). [source:swissprot;acc:o75832]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2683.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2642.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01545\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
n-myc proto-oncogene protein. [source:swissprot;acc:p04198]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4889.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14745\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
452\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alanine aminotransferase (ec 2.6.1.2) (glutamic--pyruvic transaminase) (gpt) (glutamic--alanine transaminase). [source:swissprot;acc:p24298]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1527.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1504.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01496\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger-like protein 9. [source:refseq;acc:nm\_033414]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3760.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4315.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14738\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
453\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bloom's syndrome protein (ec 3.6.1.-) (recq protein-like 3) (dna helicase, recq-like, type 2). [source:swissprot;acc:p54132]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1337.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1356.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01438\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
membrane-associated transporter protein (aim-1 protein) (melanoma antigen aim1). [source:swissprot;acc:q9umx9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3760.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
4315.06\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14738\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
454\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein-like 1 (gtp-binding protein hsr1). [source:swissprot;acc:p36915]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 1 (esg1). [source:swissprot;acc:q04724]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3219.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3174.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01402\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
455\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ga binding protein alpha chain (gabp-alpha subunit) (transcription factor e4tf1-60) (nuclear respiratory factor-2 subunit alpha). [source:swissprot;acc:q06546]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4890.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14731\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2403.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2371.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01362\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
456\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 signalosome complex subunit 1 (g protein pathway suppressor 1) (gps1 protein) (mfh protein). [source:swissprot;acc:q13098]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
17356\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17126\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01343\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ga binding protein beta-2 chain (gabp-beta-2 subunit) (transcription factor e4tf1-47) (gapbp-2) (nuclear respiratory factor-2 subunit gamma). [source:swissprot;acc:q06545]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4890.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14731\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
457\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna mismatch repair protein mlh1 (mutl protein homolog 1). [source:swissprot;acc:p40692]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1562.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1541.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01341\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 23 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-23kd) (ci-23kd) (tyky subunit). [source:swissprot;acc:o00217]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4890.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.95\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14731\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
458\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation of very long chain fatty acids protein 1 (cgi-88). [source:swissprot;acc:q9bw60]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4890.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.96\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 5 (tap-like protein 1) (tapl-1). [source:swissprot;acc:q9h1b4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2633.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2668.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01327\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
459\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
intersectin 1 (sh3 domain-containing protein 1a) (sh3p17). [source:swissprot;acc:q15811]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3774.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3821.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01266\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myc proto-oncogene protein (c-myc). [source:swissprot;acc:p01106]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4892.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5611.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14704\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
460\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
intersectin 2 (sh3 domain-containing protein 1b) (sh3p18) (sh3p18-like wasp associated protein). [source:swissprot;acc:q9nzm3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3693.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3739.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01259\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nnp-1 protein (novel nuclear protein 1) (nucleolar protein nop52) (nop52) (d21s2056e). [source:swissprot;acc:p56182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3790.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4346.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14693\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
461\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase i 16 kda polypeptide (ec 2.7.7.6) (rpa16). [source:swissprot;acc:q9y2s0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1915.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1892.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01229\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
grb2-related adaptor protein. [source:swissprot;acc:q13588]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5986.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6865.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14683\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
462\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine rich repeat (in flii) interacting protein 1. [source:refseq;acc:nm\_004735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11170.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11305\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01202\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ret finger protein 2 (leukemia associated protein 5) (b-cell chronic lymphocytic leukemia tumor suppressor leu5) (putative tumor suppressor rfp2) (tripartite motif protein 13). [source:swissprot;acc:o60858]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
11383.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9926.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14674\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
463\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent rna helicase ddx18 (dead-box protein 18) (myc-regulated dead-box protein) (mrdb). [source:swissprot;acc:q9nvp1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3720.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4264.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1463\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrofolate reductase (ec 1.5.1.3). [source:swissprot;acc:p00374]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1262.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1248.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01163\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
464\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone acetyltransferase type b subunit 2 (retinoblastoma binding protein p46) (retinoblastoma-binding protein 7) (rbbp-7). [source:swissprot;acc:q16576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4858.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5568.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1461\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
maleylacetoacetate isomerase (ec 5.2.1.2) (maai) (glutathione s- transferase zeta 1) (ec 2.5.1.18) (gstz1-1). [source:swissprot;acc:o43708]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2290.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2264.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01136\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
465\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 1b. [source:refseq;acc:nm\_004272]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6323\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6254.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01102\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/